Expected to publish as draft guidance or final guidance by the end of December 2024.
The following list of guidance topics includes possible new topics for guidance documents and/or revisions to existing guidance documents that the Office of the Chief Scientist is considering. We currently intend to develop guidance on each topic; however, the Office of the Chief Scientist is neither bound by this list of topics, nor required to issue every guidance document on this list. Several factors may impact FDA’s ability to issue a guidance, including, for example, new Administration priorities, emerging public health issues, or other extenuating circumstances. We may also issue guidance documents on topics not on this list.
You may submit comments on the guidance topics at www.regulations.gov at Docket FDA-2023-N-5020.
Guidance Document Table
|Registration and Listing of Cosmetic Product Facilities and Products
|Insanitary Conditions in the Preparation, Packing, and Holding of Tattoo Inks and the Risk of Microbial Contamination
|Conflicts of Interest and Eligibility for Participation in FDA Advisory Committees
|Appearance Concerns and Authorizations for Participation in FDA Advisory Committees
* Indicates guidance developed by FDA/ORA in collaboration with OCS.
Good Guidance Practices
- FDA's Good Guidance Practices regulation (PDF - 162KB) September 2000
- How to comment on Guidance Documents
- Federal Register: Notice to Public of Website Location of the Office of the Chief Scientist Proposed Guidance Development List